Drug Approval

Blog Post

Quest Podcast: PJ’s Protocol: A Lifesaving Procedure Fueled by Love

By MDA Staff | March 6, 2025
Medical Research Scientist Working on Desktop Computer with Gene Analysis Software in Modern Science Research Laboratory. Lab Engineers in White Coats Conduct Experiments in the Background.
Blog Post

Simply Stated: Emerging Therapies to Treat DMD

By Sujatha Gurunathan | December 20, 2024
Blog Post

MDA Ambassador Guest Blog: Finding Hope and Optimism in New Treatments

By Chase Rankin | June 4, 2024
wooden blocks spell out the word content with word bubbles above that say news and stories and photos and blog
Blog Post

In Case You Missed It…

By MDA Staff | April 8, 2024
Blog Post

FDA’s Approval of Duvyzat (givinostat) Offers New Hope to People Living with Duchenne Muscular Dystrophy

By MDA Staff | March 21, 2024
A group of MDA advocates gather in front of the United States Capitol Building on Hill Day
Blog Post

Celebrating Our 2023 Advocacy Accomplishments

By Mark Fisher | December 20, 2023
Collage image with six photos of various MDA events and supported research
Blog Post

2023 in Review: A Letter from MDA President and CEO, Dr. Wood

By Donald S. Wood, Ph.D., President and CEO, Muscular Dystrophy Association | December 11, 2023
Graphic of the inside of a human cell
Featured Article

Q&A: Understanding Metabolic Myopathies

By MDA Staff | November 17, 2023
wooden blocks spell out the word content with word bubbles above that say news and stories and photos and blog
Blog Post

In Case You Missed It…

By MDA Staff | November 8, 2023
Blog Post

AGAMREE ® (Vamorolone), Now FDA-Approved, Offers Hope for Children Living with Duchenne Muscular Dystrophy

By MDA Staff | October 26, 2023